Contract notice: Pharmaceutical products

• Country: Germany
• Summary: Contract notice: Pharmaceutical products
• DET Ref No: 40719655
• Deadline: 31 Mar 2021
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 077007-2020
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Object of the contract
  Pharmaceutical products
  
  Description: Contract notice: Pharmaceutical products
  
  Authority Type: Body governed by public law
  Contact Nature: Supplies
  Procedure: Open procedure
  Document: Contract notice
  Regulation: European Union, with participation by GPA countries
  Award criteria: Lowest price
  CPV code: 33600000,33600000,33600000
  CPV Description: Pharmaceutical products.
  Conclusion of non-exclusive discount agreements within the framework of a so-called "open-house model" for the X-ray contrast agents listed in detail under II.1.4) (ATC code according to WHO: V08).
  Reference Number: 15 / 2020- OH
  The subject of this publication is the conclusion of discount agreements for the following X-ray contrast media (ATC code according to WHO: V08):
  Main Site: BuRepublic of Germany, Free State of Saxony and Thuringia
  The subject of this lot is the conclusion of discount agreements for the active ingredient amidotrizoic acid (ATC according to WHO: V08AA01) within the framework of a so-called "open-house model". 2020. The contract is concluded as part of the open house processAOK PLUS does not guarantee individual contract partners exclusivity. The purchase quantity is unknown when the agreement is concluded and is particularly dependent on the demand of the insured, the development of the number of insured, the prescription behavior of the contract doctors and the dispensing and stockpiling behavior of the public pharmacies. The client guarantees no minimumInterested contractors can conclude discount agreements during the period from March 13, 2020 to March 31, 2021. The discount agreements and the "open-house procedure" will end at the latest on March 31, 2021, regardless of the date of the conclusion of the contract. Irrespective of this, discount agreements and the "open-house procedure" will be terminated before March 31, 2021, wAs a result of a formal award procedure in accordance with the regulations of Part 4 of the GWB, exclusive agreements on the active substances mentioned under II.1.1) come into force with one or more contractual partners Months after publication of the relevant announcement in the TEDSupplement to the Official Journal of the European Union in force. The future contractual partners are requested to inform themselves regularly about these announcements in the TED Supplement to the Official Journal of the European Union. Interested contractors can obtain the participation documents and the discount agreement from the contact point mentioned under I.1) by specifying LoRequest s and active ingredient via email. A precondition for the conclusion of a discount agreement is that the interested contractor has completed, signed, dated and provided the company stamp with all the participation documents (self-declaration for the absence of reasons for exclusion, discount agreement in duplicate, declaration of conformity) in due timeegt. A discount agreement is concluded with each contractor who meets the eligibility requirements. The complete participation documents must be submitted by post to the contact point mentioned under I.1), for the first time by March 12th, 2020 and then by the 15th of each month (receipt period). It depends on the access at the contact point mentioned under I.1)on. If the 15th of a month falls on a Saturday, Sunday or national holiday, the next working day will take the place of such a day. If received later (after March 12, 2020 or the 15th of a month), the submitted participation documents will be taken into account on the 15th of the following monthfinally in effect on March 31, 2020 on April 1, 2020. The signing takes place until the end of the month in which the participation documents must have been received by AOK PLUS.
  The AOK health partner portal (www.aok-gesundheitpartner.de) is used for the publication of the discounted contrast media. The AOK PLUS publishes on the first day of the month after the Rabat has been signedagreement through the AOK PLUS. The first publication will take place on 1.4.2020. AOK PLUS reserves the right to make such questions and the answers to them available anonymously to all other interested contractorsIf this is of general interest in the course of the procedure.
  - Self-declaration on the absence of grounds for exclusion
  This publication is not an award of a public contract within the meaning of the Public Procurement Directive (2014/24 / EU) or public procurement law. To ensure the greatest possible degree of transparency for the intended conclusion of contractsthe publication in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting requirements ("mandatory fields"), such as the procedure designation "open procedure", "award criteria" and "conditions for opening the offers" are only of benefitowed this notice form and the publication platform. This is not associated with any further significance, in particular submission to public procurement regulations, insofar as they are not compulsory for legal reasons. The information in section VI.4) is therefore only given as an aid.
  
  Internet address (URL): https://plus.aok.de
• Documents:

 Tender Notice